A Study of E7389 in Advanced/Metastatic Breast Cancer Patients

NCT00097721 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Neoplasms

Interventions

DRUG: E7389

Sponsor

Eisai Inc.